Author details

Full Name

Robert S Epstein

Affiliation

Epstein Health LLC

ORCID

Career Start Year

1988

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36652354	Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic Cholangiocarcinoma.	N Engl J Med	2023
35421820	Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER-medicare study.	Cancer Treat Res Commun	2022
35614009	Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes.	Clin Lymphoma Myeloma Leuk	2022
33347420	Attitudes and Perceptions Toward COVID-19 Digital Surveillance: Survey of Young Adults in the United States.	JMIR Form Res	2021
33658769	Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life.	Patient Prefer Adherence	2021
34636250	Real-world use and outcomes of hypomethylating agent therapy in higher-risk myelodysplastic syndromes: why are we not achieving the promise of clinical trials?	Future Oncol	2021
32642965	Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors.	Adv Ther	2020
30367388	Practice Patterns and Treatment Challenges in Acute Postoperative Pain Management: A Survey of Practicing Physicians.	Pain Ther	2018
28181146	When People with Opioid-Induced Constipation Speak: A Patient Survey.	Adv Ther	2017
28167571	Pharmacoepidemiology of Clinically Relevant Hypothyroidism and Hypertension from Sunitinib and Sorafenib.	Oncologist	2017
25494232	Patient-Focused Drug Development: A New Direction for Collaboration.	Med Care	2015
24634402	Characterizing genetic variants for clinical action.	Am J Med Genet C Semin Med Genet	2014
25414049	Patient preferences for change in symptoms associated with opioid-induced constipation.	Adv Ther	2014
24747235	Mobile medical applications: old wine in new bottles?	Clin Pharmacol Ther	2014
23337523	Pharmacy benefit managers and their obligations during serious prescription drug shortages.	Clin Pharmacol Ther	2013
23882433	Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials.	Innov Clin Neurosci	2013
22278335	Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.	Clin Pharmacol Ther	2012
24237318	Integrating new approaches for clinical development: translational research and relative effectiveness.	J Comp Eff Res	2012
24237317	Integrating scientific and real-world evidence within and beyond the drug development process.	J Comp Eff Res	2012
24237316	A framework for pharmaceutical value-based innovations.	J Comp Eff Res	2012
24237315	R&D transformation and value-based innovation.	J Comp Eff Res	2012
23048101	The hypothetical migraine drug comparative effectiveness study: a payer's recommendations for obtaining more useful results.	Health Aff (Millwood)	2012
22869663	Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually.	Health Aff (Millwood)	2012
22513307	The many sides of off-label prescribing.	Clin Pharmacol Ther	2012
21454729	Medication adherence: hope for improvement?	Mayo Clin Proc	2011
20381283	Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).	J Am Coll Cardiol	2010
20831298	Comparative effectiveness research and personalized medicine: catalyzing or colliding?	Pharmacoeconomics	2010
20921476	Comparative effectiveness and personalized medicine: evolving together or apart?	Health Aff (Millwood)	2010
20962775	Pharmacy benefit managers: evaluating clinical utility in the real world.	Clin Pharmacol Ther	2010
20944079	Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.	J Natl Cancer Inst	2010
20653354	Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.	Pharmacotherapy	2010
19102724	Payer perspectives on pharmacogenomics testing and drug development.	Pharmacogenomics	2009
18680656	Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-2005.	Emerg Infect Dis	2008
18657016	Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.	Pharmacotherapy	2008
18714320	What's needed for personalized therapy in smoking cessation.	Clin Pharmacol Ther	2008
17449832	Trends in medication treatment for ADHD.	J Atten Disord	2007
17850526	The effect of three-tier formulary adoption on medication continuation and spending among elderly retirees.	Health Serv Res	2007
15908846	Impact of medication adherence on hospitalization risk and healthcare cost.	Med Care	2005
16232024	Dispensing error rate in a highly automated mail-service pharmacy practice.	Pharmacotherapy	2005
15809411	Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.	Arch Gen Psychiatry	2005
14657430	The effect of incentive-based formularies on prescription-drug utilization and spending.	N Engl J Med	2003
10703933	Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss.	J Bone Miner Res	2000
10982094	Responsiveness in quality-of-life assessment: nomenclature, determinants, and clinical applications.	Med Care	2000
10525712	Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group.	Osteoporos Int	1999
10393145	Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial.	Am J Clin Nutr	1999
9817939	Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women.	Calcif Tissue Int	1998
16674547	A pharmacy benefit manager perspective.	Value Health	1998
9651908	Are menopausal symptoms associated with bone mineral density and changes in bone mineral density in premenopausal women?	Maturitas	1998
9553534	Eight-year outcome associated with clinical options in the management of femoral neck fractures.	Clin Orthop Relat Res	1998
9682793	Intervention thresholds for the treatment of osteoporosis: comparison of different approaches to decision-making.	Osteoporos Int	1998

1 - 50 of 90

Cara Joyce

Loyola University

Career Start Year 2010

Number of shared co-authors 0

Christine Y Lu

Harvard Medical School and the Harvard Pilgrim Health Care Institute

Career Start Year 2004

Number of shared co-authors 5

June M McKoy

Feinberg School of Medicine, Northwestern University

Career Start Year 2003

Number of shared co-authors 0

Nilay D Shah

Mayo Clinic

Career Start Year 2002

Number of shared co-authors 1

Joseph S Ross

Yale School of Medicine

Career Start Year 1999

Number of shared co-authors 0

Chi-Hong Tseng

David Geffen School of Medicine, University of California los angeles

Career Start Year 1998

Number of shared co-authors 0

Emily Beth Devine

University of Washington

Career Start Year 1997

Number of shared co-authors 7

Sebastian Schneeweiss

Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School

Career Start Year 1996

Number of shared co-authors 2

George Caleb Alexander

Institute of General Practice and Family Medicine, University Hospital

Career Start Year 1996

Number of shared co-authors 3

Paul J Nietert

Medical University of South Carolina

Career Start Year 1996

Number of shared co-authors 0

George Tomlinson

University Health Network

Career Start Year 1994

Number of shared co-authors 0

Paul J Novotny

Mayo Clinic

Career Start Year 1994

Number of shared co-authors 1

David O Meltzer

The University of Chicago

Career Start Year 1993

Number of shared co-authors 3

Sally C Morton

Virginia Commonwealth University

Career Start Year 1993

Number of shared co-authors 0

Jason N Doctor

University of Southern California

Career Start Year 1992

Number of shared co-authors 1

Jesse A Berlin

Rutgers University School of Public Health

Career Start Year 1988

Number of shared co-authors 2

Mark G Weiner

Weill Cornell Medical College

Career Start Year 1987

Number of shared co-authors 1

Joel Tsevat

Dell Medical School, University of Texas at Austin

Career Start Year 1987

Number of shared co-authors 0

Timothy S Carey

University of North Carolina at Chapel Hill

Career Start Year 1986

Number of shared co-authors 2

Charles L Bennett

University of South Carolina

Career Start Year 1986

Number of shared co-authors 3

Theodore G Ganiats

university of california san diego

Career Start Year 1983

Number of shared co-authors 1

Elizabeth A Chrischilles

University of Iowa, School of Public Health

Career Start Year 1982

Number of shared co-authors 2

Roger B Davis

Beth Israel Deaconess Medical Center

Career Start Year 1982

Number of shared co-authors 0

Endel J Orav

Brigham and Women's Hospital

Career Start Year 1982

Number of shared co-authors 2

Dale F Kraemer

6 Department of Medical Informatics and Clinical Epidemiology.

Career Start Year 1981

Number of shared co-authors 0

Stephan D Fihn

University of Washington

Career Start Year 1980

Number of shared co-authors 1

Dennis W Raisch

The University of New Mexico

Career Start Year 1977

Number of shared co-authors 0

Barbara C Tilley

University of Texas Health Science Center, School of Public Health at Houston

Career Start Year 1977

Number of shared co-authors 0

Stan N Finkelstein

University of Toronto

Career Start Year 1977

Number of shared co-authors 1

Brian L Strom

Center for Pharmacoepidemiology and Treatment Science, Rutgers University

Career Start Year 1970

Number of shared co-authors 2

row(s) 1 - 30 of 30

Eva Lydick

SmithKline Beecham Pharmaceuticals, Collegeville

Co-authored papers 9

Jane A Cauley

School of Public Health, University of Pittsburgh

Co-authored papers 7

Patricia A Deverka

Deverka Consulting LLC

Co-authored papers 6

Cynthia J Girman

University of North Carolina at Chapel Hill

Co-authored papers 4

Joseph E. Oesterling

Mayo Clinic

Co-authored papers 3

Michael M Lieber

Mayo Clinic College of Medicine

Co-authored papers 3

Howard L McLeod

Center for Precision Medicine and Functional Genomics, Utah Tech University

Co-authored papers 3

Robert E Ferrell

Co-authored papers 3

Laurel A Panser

Section of Health Services Evaluation, Mayo Clinic

Co-authored papers 3

Skai W Schwartz

College of Public Health, University of South Florida

Co-authored papers 2

Donald L Patrick

School of Public Health, 4University of Washington

Co-authored papers 2

Lawrence J Lesko

Department of Pharmaceutics, University of Florida

Co-authored papers 2

Christopher G Chute

Brown University, Brown University Warren Alpert Medical School, Dartmouth-Hitchcock Medical Center, Harvard School of Public Health, Johns Hopkins Medicine, Mayo Clinic Minnesota

Co-authored papers 2

Harry A Guess

University of North Carolina at Chapel Hill

Co-authored papers 2

Matthew E Hurles

Wellcome Sanger Institute

Co-authored papers 1

Christopher J O'Donnell

Brigham and Women's Hospital, Harvard Medical School

Co-authored papers 1

Erin M Ramos

National Human Genome Research Institute